Kinnate Biopharma Inc
(KNTE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,998 | 51,662 | 34,507 | 73,570 | 54,986 |
| Marketable Securities | 97,036 | 115,914 | 150,196 | 127,411 | 172,214 |
| TOTAL | $158,177 | $170,301 | $188,600 | $205,288 | $230,837 |
| Non-Current Assets | |||||
| PPE Net | 2,272 | 2,470 | 2,667 | 2,877 | 3,071 |
| Investments And Advances | 10,259 | 12,762 | 19,579 | 30,203 | 39,139 |
| Other Non-Current Assets | 2,897 | 5,176 | 5,289 | 5,512 | 5,779 |
| TOTAL | $15,428 | $20,408 | $27,535 | $38,592 | $47,989 |
| Total Assets | $173,605 | $190,709 | $216,135 | $243,880 | $278,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,031 | 2,929 | 2,696 | 4,451 | 2,970 |
| Accrued Expenses | 9,072 | 11,976 | 12,118 | 12,721 | 13,206 |
| TOTAL | $11,995 | $15,774 | $15,773 | $18,155 | $17,167 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,283 | 2,515 | 2,742 | 2,963 | 38,191 |
| TOTAL | $2,283 | $2,515 | $2,742 | $2,963 | $38,191 |
| Total Liabilities | $14,278 | $18,289 | $18,515 | $21,118 | $55,358 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,225 | 47,113 | 47,095 | 46,573 | 46,570 |
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -372,012 | -354,954 | -324,221 | -292,303 | -259,363 |
| Other shareholders' equity | -12 | -147 | -342 | -464 | -1,410 |
| TOTAL | $159,327 | $172,420 | $197,620 | $222,762 | $223,468 |
| Total Liabilities And Equity | $173,605 | $190,709 | $216,135 | $243,880 | $278,826 |